A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, metyrapone (Metopirone®), and the benzodiazepine receptor agonist, oxazepam (original trade name Serax®; now marketed as oxazepam (generic) only). This Phase 1b cocaine interaction study is being conducted in order to assess the safety and PK of EMB-001 and cocaine in combination.
Epistemonikos ID: c14b409a5f27cb4500d5d62b998633ab1d783910
First added on: May 17, 2024